Physician profile
Kenneth Spector
NPI 1497818462
$2,299.10
in general payments reported to CMS, 2019-2025
22 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $84.01 · 2021: $419 · 2022: $102 · 2023: $165 · 2024: $133 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $392.63 | 2021 | |
| Novartis Pharmaceuticals Corporation | $370.55 | 2019-2025 | |
| Amgen INC. | $319.82 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $255.95 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $175.45 | 2019 | |
| Pfizer INC. | $111.91 | 2019 | |
| Boston Scientific Corporation | $87.52 | 2019-2025 | Watchman Flx, Watchman Access System |
| Sanofi-Aventis U.S. LLC | $78.46 | 2019 | |
| Ge Healthcare | $73.28 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.89 | 2019-2024 | Lifevest |
| Lundbeck LLC | $55.95 | 2019 | |
| Heartflow, INC. | $49.87 | 2024 | |
| Alnylam Pharmaceuticals INC. | $49.24 | 2022-2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $47.57 | 2019-2022 | |
| Medtronic Vascular, INC. | $27.07 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $23.76 | 2022 | |
| Philips North America LLC | $23.65 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.88 | 2019 | |
| Preventice Services, LLC | $20.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.26 | 2019 | |
| Inspire Medical Systems, INC. | $18.21 | 2025 | Inspire |
| Amarin Pharma, INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Spector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.